Imagion Biosystems is a biotech company aiming to make a difference to the lives of cancer patients, with groundbreaking imaging techniques being trialled in Australian hospitals.
CEO Bob Proulx joins Sean Aylmer from San Diego to talk about Imagion's work, and why they chose to list on the ASX.

Rates to rise as war goes on; auction market tumbles; YouTube biggest media company
18:43

Q+A: The Week Ahead | 16 Mar 2026
12:27

Five Questions: When was the last time someone handed you cash?
11:30